Clinical Trial Update: Phase 2 Fludarabine, Cytoxan and FCCAM <Alemtuzumab> in Untreated B-Cell Chronic Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial of fludarabine, cyclophosphamide and alemtuzumab in untreated B-cell chronic lymphocytic leukemia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Alemtuzumab (Alemtuzumab)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine (Fludarabine)

Snippet

Sponsor: Steven E. Coutre | Conditions: Leukemia, B-cell Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2014-09-08